Sanofi says new products will beat consensus by EUR 5B

On its annual analyst call Thursday, Sanofi (Euronext:SAN; NYSE:SNY) said it plans to launch 18 new products by 2020 with cumulative sales of EUR 30 billion. Interim CEO and Chairman Serge Weinberg said the projection is EUR 5 billion over the analyst consensus sales estimates of EUR 25 billion for the new products over that period.

The new products include one animal health product, five vaccines, four drugs approved in 2014 and eight drug candidates in registration, Phase III or Phase II. ...